# Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent Tumors

> **NCT04889742** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Charite University, Berlin, Germany** · enrollment: 110 (estimated)

## Conditions studied

- Recurrent Cancer
- Prostate Cancer
- Cervical Cancer
- Anal Cancer
- Sarcoma
- Rectal Cancer
- Neuroendocrine Tumors
- Esophageal Cancer
- Pancreas Cancer
- Squamous Cell Carcinoma

## Interventions

- **DEVICE:** loco-regional hyperthermia

## Key facts

- **NCT ID:** NCT04889742
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-05-10
- **Primary completion:** 2026-01
- **Final completion:** 2028-01
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2023-12-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04889742

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04889742, "Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent Tumors". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04889742. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*